NL6514950A - - Google Patents
Info
- Publication number
- NL6514950A NL6514950A NL6514950A NL6514950A NL6514950A NL 6514950 A NL6514950 A NL 6514950A NL 6514950 A NL6514950 A NL 6514950A NL 6514950 A NL6514950 A NL 6514950A NL 6514950 A NL6514950 A NL 6514950A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B57/00—Separation of optically-active compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US411704A US3405159A (en) | 1964-11-17 | 1964-11-17 | Process for resolving racemic mixtures of optically-active enantiomorphs |
Publications (2)
Publication Number | Publication Date |
---|---|
NL6514950A true NL6514950A (de) | 1966-05-18 |
NL151050B NL151050B (nl) | 1976-10-15 |
Family
ID=23629969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL656514950A NL151050B (nl) | 1964-11-17 | 1965-11-17 | Werkwijze voor het scheiden van racematen. |
Country Status (6)
Country | Link |
---|---|
US (1) | US3405159A (de) |
BR (1) | BR6574171D0 (de) |
CH (1) | CH491835A (de) |
DE (1) | DE1543238B1 (de) |
GB (1) | GB1092748A (de) |
NL (1) | NL151050B (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3505385A (en) * | 1962-10-11 | 1970-04-07 | Merck & Co Inc | Alpha-lower alkanoylamino - alpha - hydroxy and/or methoxy substituted benzyl propionitriles |
GB1211589A (en) * | 1968-08-06 | 1970-11-11 | Ici Ltd | Enantiomer isolation process |
JPS5136261B1 (de) * | 1970-07-11 | 1976-10-07 | ||
US4115443A (en) * | 1975-01-10 | 1978-09-19 | Veb Jenapharm | Process of making D,L-lithium pantoate and resolving the racemic mixture into its optically active isomers |
US3953504A (en) * | 1975-03-18 | 1976-04-27 | Nippon Peroxide Co., Ltd. | Racemization of optically active tartaric acid |
CH635563A5 (fr) * | 1977-07-07 | 1983-04-15 | Sumitomo Chemical Co | Procede pour la preparation d'un alpha-cyano-3-phenoxybenzyle optiquement actif. |
JPS57145830A (en) * | 1981-03-06 | 1982-09-09 | Hiroyuki Nohira | Optical resolution of 2-(4-chlorophenyl)-3-methylbutanoic acid |
ZA852843B (en) * | 1984-05-15 | 1985-11-27 | Warner Lambert Co | Bevantolol preparation |
JPH0684332B2 (ja) * | 1985-06-20 | 1994-10-26 | 住友化学工業株式会社 | a−イソプロピル−p−クロルフエニル酢酸の光学分割法 |
US5039801A (en) * | 1985-12-20 | 1991-08-13 | The United States Of America As Represented By The Department Of Health & Human Services | Thermal fragmentation of methylbenzylurea disastereomers or secondary amines and preparation of optically active secondary amines |
US4716246A (en) * | 1986-08-22 | 1987-12-29 | Merck & Co., Inc. | Process for L-dopa |
US4863962A (en) * | 1988-03-02 | 1989-09-05 | Fidia-Georgetown Institute For The Neurosciences | D-DOPA, pharmaceutically acceptable salts thereof, and methods of treating Parkinson's disease |
US5202260A (en) * | 1991-05-08 | 1993-04-13 | Genzyme Corporation | Resolution of α-tertiary carboxylic acid esters using lipase from Candida lipolytica |
CA2068038A1 (en) * | 1991-05-08 | 1992-11-09 | Christopher Yee | Enzymatic resolution of .alpha.-tertiary carboxylic acid esters |
US5189208A (en) * | 1991-07-01 | 1993-02-23 | Ethyl Corporation | Ibuprofen resolution |
US5369120A (en) * | 1993-07-28 | 1994-11-29 | Warner-Lambert Company | Pharmaceutical composition of 7-((substituted)amino-8-((substituted)carbonyl)-(methylamino)-1-oxasp iro(4,5)decanes and L-dopa |
US6548484B1 (en) | 2000-04-12 | 2003-04-15 | International Medical Innovations, Inc. | Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation |
US20060241183A1 (en) * | 2004-09-28 | 2006-10-26 | Farouk Karoum | Compositions and methods of using D-DOPA to treat Parkinson's disease |
WO2007011701A1 (en) * | 2005-07-15 | 2007-01-25 | Transform Pharmaceuticals, Inc. | Novel hydrochloride salts of levodopa |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2734919A (en) * | 1956-02-14 | Method of resolving dl-threo-l- | ||
US2767213A (en) * | 1952-12-30 | 1956-10-16 | Parke Davis & Co | Resolution of methylmercaptophenylaminopropane-diol |
-
1964
- 1964-11-17 US US411704A patent/US3405159A/en not_active Expired - Lifetime
-
1965
- 1965-10-19 BR BR174171/65A patent/BR6574171D0/pt unknown
- 1965-11-10 GB GB47726/65A patent/GB1092748A/en not_active Expired
- 1965-11-11 CH CH1556665A patent/CH491835A/de not_active IP Right Cessation
- 1965-11-16 DE DE19651543238 patent/DE1543238B1/de not_active Withdrawn
- 1965-11-17 NL NL656514950A patent/NL151050B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
NL151050B (nl) | 1976-10-15 |
DE1543238B1 (de) | 1970-07-30 |
GB1092748A (en) | 1967-11-29 |
US3405159A (en) | 1968-10-08 |
CH491835A (de) | 1970-06-15 |
BR6574171D0 (pt) | 1973-08-14 |